Antimalarial peptides (AMAPs) varying in length, amino
acid composition,
charge, conformational structure, hydrophobicity, and amphipathicity
reflect their diversity in antimalarial mechanisms. Due to the worldwide
major health problem concerning antimicrobial resistance, these peptides
possess great therapeutic value owing to their low incidences of drug
resistance as compared to conventional antibiotics. Although well-known
experimental methods are able to precisely determine the antimalarial
activity of peptides, these methods are still time-consuming and costly.
Thus, machine learning (ML)-based methods that are capable of identifying
AMAPs rapidly by using only sequence information would be beneficial
for the high-throughput identification of AMAPs. In this study, we
propose the first computational model (termed iAMAP-SCM) for the large-scale
identification and characterization of peptides with antimalarial
activity by using only sequence information. Specifically, we employed
an interpretable scoring card method (SCM) to develop iAMAP-SCM and
estimate propensities of 20 amino acids and 400 dipeptides to be AMAPs
in a supervised manner. Experimental results showed that iAMAP-SCM
could achieve a maximum accuracy and Matthew’s coefficient
correlation of 0.957 and 0.834, respectively, on the independent test
dataset. In addition, SCM-derived propensities of 20 amino acids and
selected physicochemical properties were used to provide an understanding
of the functional mechanisms of AMAPs. Finally, a user-friendly online
computational platform of iAMAP-SCM is publicly available at . The iAMAP-SCM predictor is anticipated to assist experimental scientists
in the high-throughput identification of potential AMAP candidates
for the treatment of malaria and other clinical applications.